Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery

J Ocul Pharmacol Ther. 2009 Aug;25(4):385-6; author reply 386. doi: 10.1089/jop.2008.0145.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage*
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Benzeneacetamides / administration & dosage*
  • Benzeneacetamides / therapeutic use
  • Cataract Extraction / adverse effects
  • Clinical Trials as Topic / methods
  • Drug Administration Schedule
  • Drug Approval / legislation & jurisprudence
  • Humans
  • Inflammation / drug therapy
  • Inflammation / etiology
  • Pain, Postoperative / drug therapy
  • Pain, Postoperative / etiology
  • Phenylacetates / administration & dosage*
  • Phenylacetates / therapeutic use
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Benzeneacetamides
  • Phenylacetates
  • nepafenac